Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Bladder cancer, Cystectomy, Internal medicine, Proportional hazards model, and Stage (stratigraphy).
A novel grading approach predicts worse outcomes in stage <scp>pT1</scp> non‐muscle‐invasive bladder cancer
Innervation pattern of the unclosed detrusor muscle in classic bladder exstrophy: a study of patients with urothelial overexpression of nerve growth factor
Recurrent Cystitis in Women—A Real-World Analysis of Bacteria Spectrum and Resistance Situation for Calculated Therapy
Amoxicillin/Clavulanic Acid in Transrectal Biopsy of the Prostate—An Alternative in Times of Ciprofloxacin Obsolescence and Fosfomycin Limitation?
Antibiotic Prophylaxis of Transrectal Biopsy of the Prostate: A Plea for Fosfomycin
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma
Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort
Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non–muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guérin Immunotherapy
cMET: a prognostic marker in papillary renal cell carcinoma?
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis
Evaluation of a microRNA-based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
Geriatric Patients and Symptomatic Urinary Tract Infections: Analysis of Bacterial Range and Resistance Rates at a 3rd Level of Care Hospital in Germany
Expression of Low Affinity Nerve Growth Factor Receptor p75 in Classic Bladder Exstrophy
Impact of Male Patient Information on Quality of Urine Examination (PIQUE Study)
Erratum zu: Wechselwirkungen von radikaler Prostatovesikulektomie und Diagnostik des Prostatakarzinoms
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study
Radical Prostatectomy: from Open Surgery towards Robotic Laparoscopy
Wechselwirkungen von radikaler Prostatovesikulektomie und Diagnostik des Prostatakarzinoms
758P Assessment of prognostic and predictive value of FGFR alterations (FGFRa) in a real-world cohort of patients (pts) with high-risk pT1 non-muscle-invasive bladder cancer (NMIBC)
Abstract B23: <i>FGFR3</i> mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
Abstract PR04: Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes
Wechselwirkungen von radikaler Prostatovesikulektomie und Diagnostik des Prostatakarzinoms